Agenus Inc (AGEN)
4.97
-0.43
(-7.96%)
USD |
NASDAQ |
Apr 18, 16:00
4.97
0.00 (0.00%)
After-Hours: 07:18
Agenus Cash from Operations (Quarterly): -40.40M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -40.40M |
September 30, 2023 | -65.23M |
June 30, 2023 | -60.04M |
March 31, 2023 | -58.53M |
December 31, 2022 | -47.34M |
September 30, 2022 | -32.19M |
June 30, 2022 | -43.45M |
March 31, 2022 | -52.39M |
December 31, 2021 | -22.93M |
September 30, 2021 | 131.37M |
June 30, 2021 | -55.56M |
March 31, 2021 | -42.74M |
December 31, 2020 | -35.59M |
September 30, 2020 | -31.63M |
June 30, 2020 | -37.38M |
March 31, 2020 | -34.50M |
December 31, 2019 | -31.78M |
September 30, 2019 | -27.78M |
June 30, 2019 | -35.70M |
March 31, 2019 | 76.59M |
December 31, 2018 | -35.81M |
September 30, 2018 | -24.50M |
June 30, 2018 | -30.53M |
March 31, 2018 | -40.25M |
December 31, 2017 | -25.87M |
Date | Value |
---|---|
September 30, 2017 | -26.15M |
June 30, 2017 | -27.38M |
March 31, 2017 | -14.83M |
December 31, 2016 | -16.12M |
September 30, 2016 | -23.82M |
June 30, 2016 | -18.49M |
March 31, 2016 | -21.53M |
December 31, 2015 | -19.59M |
September 30, 2015 | -18.01M |
June 30, 2015 | -12.87M |
March 31, 2015 | 3.295M |
December 31, 2014 | -10.51M |
September 30, 2014 | -8.106M |
June 30, 2014 | -9.496M |
March 31, 2014 | -10.12M |
December 31, 2013 | -5.544M |
September 30, 2013 | -4.431M |
June 30, 2013 | -5.663M |
March 31, 2013 | -3.895M |
December 31, 2012 | -3.277M |
September 30, 2012 | -3.636M |
June 30, 2012 | -3.346M |
March 31, 2012 | 11.27M |
December 31, 2011 | -4.180M |
September 30, 2011 | -3.398M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-65.23M
Minimum
Sep 2023
131.37M
Maximum
Sep 2021
-32.83M
Average
-37.38M
Median
Jun 2020
Cash from Operations (Quarterly) Benchmarks
Protalix BioTherapeutics Inc | 3.595M |
InfuSystems Holdings Inc | 4.658M |
PAVmed Inc | -11.87M |
Allogene Therapeutics Inc | -53.71M |
Pfizer Inc | 5.24B |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 2.824M |
Cash from Financing (Quarterly) | 7.315M |
Free Cash Flow | -234.16M |
Free Cash Flow Per Share (Quarterly) | -2.116 |
Free Cash Flow to Equity (Quarterly) | -40.43M |
Free Cash Flow Yield | -263.4% |